IPRsonline.org
Resources
Education
Resources
Resources
Resources



POLICY OPTIONS FOR ASSURING AFFORDABLE ACCESS TO ESSENTIAL MEDICINES
The Bellagio Series on Development and Intellectual Property Policy

At the Rockefeller Foundation's Bellagio Study and Conference Center on Lake Como in Northern Italy,
12 - 16 October 2004

Description | Programme | Participants | Documentation

  Documents

 

Meeting Report: Bellagio Dialogue on Ensuring Policy Options for Affordable Access to Essential Medicines, Bellagio, Italy 12 to 16 October 2004.

Conclusions of the Dialogue: Bellagio Dialogue on Ensuring Policy Options for Affordable Access to Essential Medicines, Bellagio, Italy 12 to 16 October 2004.

The cycle of action and reaction: Latest developments and trends in IP and health by Frederick ABBOTT, Florida State University.

Intellectual property and pharmaceutical data exclusivity in the context of innovation and market access by Meir Perez PUGATCH, University of Haifa.

Product development partnerships on ‘neglected diseases’: How they handle intellectual property and how this may contribute to improving access to pharmaceuticals for HIV/AIDS, TB and Malaria by Roy WIDDUS, Global Forum for Health Research.

Creating And Promoting Domestic Drug Manufacturing Capacities: Legal And Economic Feasibility Assessment by Juan ROVIRA, University of Barcelona, Spain and SOIKOS.

Role, Perspectives and Challenges of the Generic Pharmaceutical Industry in Latin America by Mirta LEVIS, Centro Industrial de Laboratorios Farmaceutícos Argentinos.

Advancing public health by other means: Using competition policy to increase access to essential medicines by Jonathan BERGER, University of the Witwatersrand.

Market Concentration Of The Transnational Pharmaceutical Industry And The Generic Industries In The World: Latest Trends on Mergers, Acquisitions and Other Transactions by Barbara ROSENBERG, Ministry of Justice, Brazil.

 

 


© ICTSD 2004 - Last Update: 05-Oct-2009